• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“原始抗原性失误”是否使印度的新冠疫苗接种行动复杂化?

Is 'original antigenic sin' complicating indian vaccination drive against Covid-19?

机构信息

Department of Pediatrics, Mangla Hospital & Research Center, Bijnor, India.

出版信息

Hum Vaccin Immunother. 2021 Oct 3;17(10):3314-3315. doi: 10.1080/21645515.2021.1945904. Epub 2021 Jun 29.

DOI:10.1080/21645515.2021.1945904
PMID:34185632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8437463/
Abstract

India is in the grip of a devastating second wave of Covid-19. Many experts believe new variants of concern (VOC) are behind this unprecedented surge. Some media reports are hinting toward higher risk of Covid infection following Covid vaccinations. 'Original antigenic sin,' in which a prior exposure to an antigen leads to an ineffective response to a related antigen, may offer one immunological explanation for this unusual association. There is an urgent need of undertaking a detailed study to prove/disprove this association.

摘要

印度正遭受第二波毁灭性的新冠疫情冲击。许多专家认为,新的关切变种(VOC)是造成这波前所未有的疫情激增的原因。一些媒体报道暗示,接种新冠疫苗后,感染新冠的风险可能会增加。“原始抗原原罪”,即先前接触一种抗原会导致对相关抗原的无效反应,可能为这种不寻常的关联提供了一种免疫学解释。现在迫切需要进行一项详细的研究来证明/反驳这种关联。

相似文献

1
Is 'original antigenic sin' complicating indian vaccination drive against Covid-19?“原始抗原性失误”是否使印度的新冠疫苗接种行动复杂化?
Hum Vaccin Immunother. 2021 Oct 3;17(10):3314-3315. doi: 10.1080/21645515.2021.1945904. Epub 2021 Jun 29.
2
SARS-CoV-2 vaccination washes away original antigenic sin.新型冠状病毒2型疫苗接种消除了原始抗原罪。
Trends Immunol. 2022 Apr;43(4):271-273. doi: 10.1016/j.it.2022.02.009. Epub 2022 Feb 28.
3
Original antigen sin and COVID-19: implications for seasonal vaccination.原始抗原决定簇与 COVID-19:对季节性疫苗接种的影响。
Expert Opin Biol Ther. 2022 Nov;22(11):1353-1358. doi: 10.1080/14712598.2022.2137402. Epub 2022 Oct 18.
4
SARS-CoV-2 vaccination in the context of original antigenic sin.SARS-CoV-2 疫苗接种与原始抗原性错误。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1949953. doi: 10.1080/21645515.2021.1949953. Epub 2021 Jul 9.
5
Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2.“原始抗原罪”在针对新型冠状病毒SARS-CoV-2变体疫苗接种中的潜在影响。
Rev Clin Esp (Barc). 2022 Feb;222(2):91-92. doi: 10.1016/j.rceng.2021.05.005. Epub 2021 Sep 14.
6
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.
7
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.既往感染与疫苗接种产生针对 SARS-CoV-2 变异株的中和抗体效力。
mBio. 2021 Dec 21;12(6):e0265621. doi: 10.1128/mBio.02656-21. Epub 2021 Dec 7.
8
The "original antigenic sin" and its relevance for SARS-CoV-2 (COVID-19) vaccination.“原始抗原罪”及其与严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新型冠状病毒肺炎)疫苗接种的相关性。
Clin Immunol Commun. 2021 Dec;1:13-16. doi: 10.1016/j.clicom.2021.10.001. Epub 2021 Oct 8.
9
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.印度基于灭活病毒的 SARS-CoV-2 疫苗 BBV152 的有效性:一项病例对照研究。
Lancet Infect Dis. 2022 Mar;22(3):349-356. doi: 10.1016/S1473-3099(21)00674-5. Epub 2021 Nov 23.
10
Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.原始抗原性失误:免疫记忆的负面影响及对 COVID-19 的启示。
mSphere. 2021 Mar 10;6(2):e00056-21. doi: 10.1128/mSphere.00056-21.

引用本文的文献

1
Parental Willingness and Factors Influencing COVID-19 Vaccination for Children in Saudi Arabia.沙特阿拉伯父母对儿童接种新冠疫苗的意愿及影响因素
Pediatric Health Med Ther. 2024 Jan 16;15:29-48. doi: 10.2147/PHMT.S443272. eCollection 2024.
2
SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.SARS-CoV-2 刺突蛋白疫苗诱导的免疫印迹降低了 SARS-CoV-2 感染中的核衣壳蛋白抗体反应。
J Immunol Res. 2022 Jul 29;2022:8287087. doi: 10.1155/2022/8287087. eCollection 2022.
3
Seasonal coronaviruses and SARS-CoV-2: effects of preexisting immunity during the COVID-19 pandemic.季节性冠状病毒和 SARS-CoV-2:COVID-19 大流行期间固有免疫的影响。
J Zhejiang Univ Sci B. 2022 Jun 15;23(6):451-460. doi: 10.1631/jzus.B2200049.

本文引用的文献

1
Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward.SARS-CoV-2 疫苗的研发:挑战、风险和未来发展方向。
Hum Vaccin Immunother. 2021 Jun 3;17(6):1635-1649. doi: 10.1080/21645515.2020.1845524. Epub 2020 Dec 3.
2
Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development.乌龟、野兔与疫苗:给新冠病毒疫苗研发的警示
Vaccine. 2020 Jun 2;38(27):4219-4220. doi: 10.1016/j.vaccine.2020.04.073. Epub 2020 May 1.
3
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.原始抗原性错误:初次接触如何塑造终身抗流感病毒免疫反应。
J Immunol. 2019 Jan 15;202(2):335-340. doi: 10.4049/jimmunol.1801149.
4
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.2008-09 季节性流感疫苗与 2009 年春夏季大流行性 H1N1 疾病的相关性:来自加拿大的四项观察性研究。
PLoS Med. 2010 Apr 6;7(4):e1000258. doi: 10.1371/journal.pmed.1000258.